Cryptoknowmics
2022-01-31 09:30:49

Blockchain to Battle Counterfeit COVID-19 Jabs in a Singapore Firm

Cryptocurrencies, particularly Bitcoin, have piqued the interest of academics, who are studying them in terms of efficiency, performance, hedging features, and relationships with traditional financial assets. Similarly, research on the influence of the latest pandemic on cryptocurrency has sprung up quickly in the aftermath of COVID-19’s breakout. Blockchain has helped quite a lot when it comes to fighting the pandemic. And now, a Singapore firm has decided to implement blockchain to battle COVID-19 jabs. To prevent practitioners from providing expired COVID-19 vaccines, Singaporean healthcare services business Zuellig Pharma is employing a blockchain-based network to track COVID-19 vaccinations. By allowing clients to instantaneously verify the provenance and authenticity of their vaccinations via a mobile app, Zuellig Pharma claims that their new ‘eZTracker’ management system can help avoid the use of improperly kept or counterfeit vaccines. SAP Blockchain to Capture, Track and Trace Multiple Data Points Daniel Laverick, vice-president and head of digital and data solutions at Zuellig Pharma said, “Accidents involving expired or improperly stored vaccines can be avoided.” To improve supply chain transparency, eZTracker uses the SAP blockchain to gather, track, and trace numerous data points. The eZTracker website describes it working with, “Simply scan the QR code on the packaging to instantly verify if your product comes fr...

Get Crypto Newsletter
Read the Disclaimer : All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured from third party sources. We make no warranties of any kind in relation to our content, including but not limited to accuracy and updatedness. No part of the content that we provide constitutes financial advice, legal advice or any other form of advice meant for your specific reliance for any purpose. Any use or reliance on our content is solely at your own risk and discretion. You should conduct your own research, review, analyse and verify our content before relying on them. Trading is a highly risky activity that can lead to major losses, please therefore consult your financial advisor before making any decision. No content on our Site is meant to be a solicitation or offer.